Reducing costs while enhancing quality of care in MS

Area of Science:

• Neurology
• Healthcare Economics

Background:

• Rising costs of disease-modifying therapies (DMTs) for multiple sclerosis (MS) have significantly increased overall MS-related healthcare expenses.
• Neurologists play a crucial role in managing MS care and are uniquely positioned to address cost containment.

Purpose of the Study:

• To outline strategies for neurologists to achieve cost containment in MS care.
• To maintain or enhance the quality of care provided to patients with MS.

Main Methods:

• The article proposes "top 5" recommendations for cost-effective MS management.
• Strategies include customizing relapse treatment, exploring alternative dosing schedules for FDA-approved DMTs, considering off-label therapies for relapse suppression, and judiciously applying DMTs based on diagnostic criteria and potential long-term benefit.

Main Results:

• The proposed strategies aim to balance medical soundness with cost-efficiency.
• Recommendations are based on existing literature and clinical experience, though rigorous Class I evidence is still developing for some approaches.

Conclusions:

• Neurologists can implement innovative management strategies to control MS healthcare costs.
• There is a call for neurologists to actively shape clinical research to establish evidence-based, cost-effective approaches for MS care.